Sweden’s pharmaceutical industry has made a huge comeback since Pharmacia was sold and Astra Zeneca closed its research in Södertälje. Now, more individually-adapted biological pharmaceuticals are growing on a broad front and many are talking about a Nordic Silicon Valley.
Sweden currently has several major Life Science clusters, with a total of 40,000 employees. Head of production for Astra Zeneca Biologics, Robert Malmberg, says, “The fact is that Astra Zeneca has invested in rough figures ten billion kronor in Sweden in the past ten years.”
We are a small, but qualified team of graduates in politics, economics, English and classics dedicated to providing quality news digests in English that offer readers a first-hand look at the most important topics covered by the Swedish press. Here you will find a selection of the articles that are published in our Swedish Press Review.